Private Capital Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$431K Sell
8,226
-9,014
-52% -$459K 0.32% 49
2022
Q1
$893K Buy
17,240
+627
+4% +$32.5K 0.2% 68
2021
Q4
$981K Buy
16,613
+41
+0.2% +$2.03K 0.21% 71
2021
Q3
$713K Buy
16,572
+993
+6% +$44K 0.16% 91
2021
Q2
$610K Buy
15,579
+800
+5% +$31.1K 0.14% 97
2021
Q1
$535K Sell
14,779
-10,196
-41% -$362K 0.13% 103
2020
Q4
$919K Buy
24,975
+68
+0.3% +$2.49K 0.17% 90
2020
Q3
$867K Sell
24,907
-1,038
-4% -$36.4K 0.18% 80
2020
Q2
$805K Buy
25,945
+917
+4% +$31.2K 0.17% 88
2020
Q1
$775K Buy
25,028
+6,429
+35% +$219K 0.2% 78
2019
Q4
$691K Sell
18,599
-11,202
-38% -$399K 0.15% 93
2019
Q3
$1.02M Buy
29,801
+4,789
+19% +$174K 0.18% 87
2019
Q2
$861K Sell
25,012
-9,322
-27% -$370K 0.2% 87
2019
Q1
$1.38M Buy
34,334
+1,021
+3% +$40.9K 0.26% 62
2018
Q4
$1.38M Buy
33,313
+4,272
+15% +$177K 0.3% 56
2018
Q3
$1.21M Buy
29,041
+915
+3% +$35.2K 0.24% 74
2018
Q2
$968K Buy
28,126
+1,281
+5% +$43.8K 0.21% 84
2018
Q1
$904K Buy
26,845
+5,671
+27% +$195K 0.2% 90
2017
Q4
$728 Buy
+21,174
New +$722K 0.17% 93

Other funds holding PFE

Private Capital Group's PFE Position: Q2 2022 in Review

Private Capital Group reduced its Pfizer (PFE) stake by 52% in Q2 2022, selling an estimated $459K and leaving 8,226 shares worth $431K. The position accounts for 0.32% of the portfolio, ranked #49.

Private Capital Group first reported a position in PFE in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.38M in Q1 2019. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Private Capital Group held 8,226 shares of Pfizer worth $431K as of Q2 2022.
  • Private Capital Group sold 9,014 Pfizer shares in Q2 2022, an estimated $459K.
  • Pfizer made up 0.32% of Private Capital Group's portfolio in Q2 2022, its #49 holding.
  • Private Capital Group first reported a position in Pfizer in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Pfizer position peaked at $1.38M in Q1 2019.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.